Dr. Andy Moye, Paige AI, on Exploring AI's Role in Transforming Cancer Diagnostics

The Pulse by Wharton Digital Health

Inhalt bereitgestellt von The Pulse by Wharton Digital Health. Alle Podcast-Inhalte, einschließlich Episoden, Grafiken und Podcast-Beschreibungen, werden direkt von The Pulse by Wharton Digital Health oder seinem Podcast-Plattformpartner hochgeladen und bereitgestellt. Wenn Sie glauben, dass jemand Ihr urheberrechtlich geschütztes Werk ohne Ihre Erlaubnis nutzt, können Sie dem hier beschriebenen Verfahren folgen https://de.player.fm/legal.

1+ y ago 45:12

MP3•Episode-Home

Archivierte Serien ("Inaktiver Feed" status)

When? This feed was archived on August 15, 2025 02:35 (4M ago). Last successful fetch was on August 15, 2025 02:58 (4M ago)

Why? Inaktiver Feed status. Unsere Server waren nicht in der Lage einen gültigen Podcast-Feed für einen längeren Zeitraum zu erhalten.

What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.

In this episode, I sat down with Dr. Andy Moye, CEO of Paige AI. Founded in 2017, Paige is a digital pathology software provider that uses AI to improve cancer diagnoses. Paige is currently the only company with FDA approval for an AI based product, and they are also collaborating with Microsoft to build the world's largest image-based AI cancer model. In this episode, Dr. Moye and I discuss the journey of Paige's origin as a spin-out from Memorial Sloan Kettering, the role of AI in supporting cancer diagnostics, the process of navigating corporate partnerships and FDA approval with AI tools, and the value of new AI applications in healthcare.

115 Episoden

#Tech #Wharton Digital Health